LSI's Select Alumni (Return) Presenters Announced Soon!
LSI Europe '22
Confirmed Presenting Companies
Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality.
Kasper Bourdette, Head of Commercialization Acorai
Inner Cosmos' digital pill is a subcutaneously implanted brain-computer interface (BCI) to rebalance the brain. The device delivers precision micro-stimulations to focused networks within the brain, without the need for invasive neurosurgery that is typically required by other neuromodulation devices. The company is initially focused on developing their solution for the treatment of depression.
Braingrade is developing an brain-machine interface intended to preserve brain health and enhance human cognition. The device is being developed for use in patient's suffering from Alzheimer's disease to improve their quality of life and extend their lifespan beyond what is capable today with medications.
Virtonomy has developed an end-to-end digital twin and simulation solution to perform clinical development and testing in a virtual environment to accelerate development and reduce risks, expenses, and regulatory burdens. The company's virtual trial platform creates virtual patient cohorts based on real clinical data to reflect anatomical variability, demographic diversity, and pathological conditions.
Empress Medical is developing the Empress system, a non-thermal system for the treatment of symptomatic uterine fibroids. The system applies sutures around the fibroid to increase intra-tumoral pressure that induces fibroid ischemia.
Innoventions Med is developing an innovative, easy-to-use, reusable device for women suffering from incontinence. The PEONY device uses technology that promotes selective muscle tissue proliferation to reinforce the pelvic floor and treat pelvic floor weakness and incontinence.
Affluent Medical is a next-generation prostheses developer building a portfolio of therapies for the treatment of cardiovascular and urological diseases. The company's cardiovascular products consist of the Kalios annuloplasty device that can be adjusted percutaneously and the Epygon, a bio-prosthesis for transapical mitral valve replacement. To address stress urinary incontinence, the company is developing Artus, a remote-controlled implant that returns control of voiding to patients suffering from this condition.
Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Our innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Backed by years of laboratory research, a strong IP and tech transfer position, and contract manufacturing partners, the company is opening a $10M Series A round to launch human clinical trials.
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.
SurePulse Medical has developed SurePulse VS, a wireless heart rate monitor specifically designed for newborns. The technology provides opportunities for more flexible and less-invasive delivery room practices that facilitate stabilization and resuscitation.
Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.
CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.
Panaxium is using advances in bioelectronic medicine and artificial intelligence to develop neuro-restorative therapies. The company's technology aims to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.
Health Navigator (HN) is using advanced machine learning and artificial intelligence to develop a range of products and services to improve how healthcare is delivered. The company's HN Predict is a software solution designed to help clinicians identify patients at risk of adverse and preventable events by analyzing routinely collected healthcare data and transforming it into actionable data that enables predictive and reactive healthcare.
Definition Health develops a suite of digital health solutions to simplify the surgical pathway for patients and providers. The company has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries.
Sandeep Chauhan, CEO & Co-Founder Definition Health
MIM Solutions is using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries. The company is currently developing two solutons that utilize AI to help couples struggling with infertility to conceive.
TympaHealth has developed an all-in-one hearing assessment platform for use at the point-of-care, including retail stores & assisted living facilities. The platform features a high-resolution otoscope for visualizing the ear drum, real-time screening audiogram, and micro-suction for ear wax removal.
CoolSpine is developing a cerebral spinal fluid cooling system, that induces localized hypothermia to prevent neurological injuries. The system is intended to prevent paraplegia and brain damage by reducing the impact of ischemic injury in the brain and spinal cord.
Hypervision Surgical is developing an AI-driven intraoperative imaging system for wide-field tissue differentiation to identify normal tissue, nerves, blood vessels and tumors in real time. The technology is non-invasive, non-contact and does not require the use of exogenous contrast agent.
Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment.
Nurami Medical is a developer of soft tissue repair technologies that leverage the company's expertise in brain physiology, nanofibers, and biomaterials. Nurami's technology utilizes a combination of electrospun nanofiber scaffolds and advanced bioactive materials. The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.
FeelTect's Tight Alright is a connect-health platform that provides data-driven, targeted, and consistent compression therapy for the treatment of venous leg ulcers. The solution employs a point-of-care wearable pressure sensing device that optimizes traditional compression therapy to reduce healing time, frequencies in healthcare visits, and costs to treat.
NERv Technology is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.
Neuraptive is developing a novel fusion system to the repair of severed peripheral nerves. The system combines standard suture neurorrhaphy with the delivery of polyethylene glycol (PEG) to improve functional outcomes following peripheral nerve injury.
Pacertool develops PaCRTool, a solution to improve cardiac resynchronization therapy (CRT) in heart failure patients. PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing. The system also functions as a simple electrophysiology system for AV node ablations and PES.
Nitinotes' endozip is an operator independent, minimally invasive, automatic suturing system for gastroscopic restructuring for the treatment of obesity. The company's solution is intended to overcome the limitations of current bariatric treatments, including invasiveness, irreversibility, procedural complexity, and poor outcomes due to technique limitations.
Green Sun Medical is developing a technology-enabled spinal brace that applies reduction forces dynamically, both allowing the patient to move and generate the constant corrective forces necessary to reverse deformity due to scoliosis. This is accomplished through tissue remodeling the same way orthodontic braces work on teeth.
AtaCor is developing an innovative temporary pacing system that avoids the risks associated with transvenous leads. Using a parasternal approach, a custom pacing lead is inserted into the extracardiac tissue between the ribs and pericardium. The system is being developed to be delivered via an imaging-free approach intended to reduce fluoroscopic guidance and free up the cath lab.
AccurKardia is democratizing clinical-grade, device-agnostic electrocardiogram (ECG) analysis through its AccurECG solution. AccurECG is cloud-based web application that is compatible with holter monitors and consumer wearables that collects and analyzes ECG data in real-time using artificial intelligence.
Jointechlabs develops innovative devices to harness and enhance the natural healing processes of the body. At the core of the company's solutions is its MiniTC, a closed loop medical device that can process lipoaspirate (fat) which can be applied or injected into areas of injury, inflammation or for aesthetic contouring.
Nishit Pancholi, COO & Chief Medical Officer Jointechlabs
Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges.
Edvardas Satkauskas, CEO Sentante / Inovatyvi Medicina
BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion.
VESTECK Suture-Tight catheter sutures secure endovascular aortic grafts to the aorta at the time of implant or during repair procedures. The sutures are designed to prevent graft migration and leaks that lead to expensive repair procedures.
Innovative devices using proprietary acoustic and accelerometer technology to diagnose sleep apnea. BresoTEC's sleep apnea testing products are designed to be used in the home and address major drawbacks of existing home-based monitoring solutions.
MediView is innovating healthcare delivery with a digital surgery solution that harnesses augmented reality (AR) to unlock new insights during ultrasound-based procedures, as well as during procedures in the operating room. The company's solutions enable providers to colloborate, navigate, and enhance visual capabilities.
Serac's Seracam is a high-resolution hybrid gamma camera for the molecular imaging of radio-labelled tracers wihin the body. Seracam is designed to be a truly portable solution that can be taken outside of the nuclear medicine department and to the patient, including in outpatient clinics, physician offices, ICUs, and ORs. The technology has been designed as a platform technology that can be easily modified to enhance clinical utility.
ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.
Activ Surgical is a digital surgery company developing imaging hardware and software to improve surgical outcomes. The company utilizes AI, near-infrared fluorescent imaging, and robotics to enhance surgical vizualition and navigation beyond what is visible from traditional imaging systems (e.g. endoscopy).
HeartKinetics combines seismocardiography and ballistocardiography techniques to remotely measure cardiac vital signs. The company's first solution, KINO, is a digital health platform to support heart failure patients and their physicians that uses AI to provide predictive insights to improve patient management.
Pierre-Francois Migeotte, CEO & Co-founder HeartKinetics
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.
Reveal Surgical's Sentry system is using advanced optical techniques such as Raman spectroscopy along with sophisticated machine learning algorithms to identify tissues with diffusely infiltrative cancer in vivo, while in surgery. The technology is intended to function as a non-invasive, optical biopsy tool that augments surgeons' experience with submillimeter precision to remove cancerous tissue while reducing the damage done to healthy tissue.
Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.
ElectroPhysiology Frontiers is developing a unique, "single-shot" catheter for the ablation of atrial fibrillation. The device is being designed to deliver pulsed-field ablation (PFA) and radiofrequency ablation (RFA) to provide patients with a durable solution and reduce the need for subsequent interventions.
Newronika is developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease. AlphaDBS interprets the bioelectrical neuronal activity (local field potentials, LFPs) in the brain areas where stimulation is delivered and accordingly adapts moment-by-moment the stimulation to follow patient’s clinical condition.
Neovasc is a specialty medical device company that develops and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina and Tiara for the transcatheter treatment of mitral regurgitation.
CereVasc's eShunt System is consists of an endovascularly implantable CSF shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia, extended hospitalization, and post-procedure pain management. Based on its novel design and deployment, the eShunt Implant is intended to significantly reduce failures associated with VPS systems such as infection, catheter obstruction, and over-drainage.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.
Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging.
Improving the health and wellbeing of women and their babies through personalized prenatal care. Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health.
Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application utilizing advanced AI/ML functionality. Endoluxe is positioned to disrupt the market as a vendor agnostic platform that allows clinicians to utilize their existing investment in traditional scopes and supporting devices, utilizing a portable, integrated, and feature-rich platform at 1/10th the cost of legacy products. More information can be found at Endoluxe.com.
Novel digestible monitoring system for the continuous monitoring of chronic conditions. The company's HEALTH-Dx platform utilizes an ingestible pill to continuously monitor cardiac and respiratory vital signs for up to a week at a time. The technology is being evaluated as a digital health solution for obstructive sleep apnea and opioid risk management.
BIOMODEX develops 3D printed solutions for patient-specific rehearsal and physician training using realistic models that provide biomechanical, imaging, and fluid dynamics. The company's solutions offer physicians a unique opportunity to train and practice surgery that virtual simulations do not offer. All surgical procedures can be performed on the company's models, including bone drilling, soft tissue suturing, medical device implantation and sizing, etc. Unlike other 3D printed organs, the ones printed by BIOMODEX can mimic different human tissues and organic textures thanks to a multi-material 3D printing system, a feature which allows surgeons to more accurately plan operations and surgical incisions.
Early Detection is focused on detecting cancer at its earliest stages - while the tissue is still considered precancerous. Early Detection has developed a test to detect an altered sugar associated only with precanceous and cancerous tissue. The test can be delivered at the point-of-care and provides in-office results for patients and providers.
The Bendit21 is a steerable microcatheter designed to achieve optimal navigation results in a small, tortuous vasculature. The clinician is able to rotate the tip of the microcatheter 360 degrees and achieves 180 degree distal tip deflection, without a guidewire. Bendit Technologies' microcatheter is cleared for use in coronary, neurological and peripheral indications.
Developing the Future of Tendon and Ligament Healing
Biorez is a medical device company committed to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We developed the BioBrace™ implant, the first FDA-cleared bio-inductive soft-tissue scaffold that was specifically designed and is indicated to mechanically reinforce tendons and ligaments while promoting tissue regeneration and healing. Since May of 2021, we have been selling to hospital systems and surgery centers in a limited commercial launch phase. To date, surgeons have successfully used the BioBrace in rotator cuff repairs, ACL reconstructions, Achilles’ tendon repairs, total shoulder replacements, and many other orthopedic procedures. Biorez is raising $15M in Q2 2022 to accelerate our commercial growth by building our sales channel and executing post-market clinical work to validate our best-in-class technology platform.
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR). A proprietary artificial intelligence (AI) algorithm analyzes these findings to assess brain health and predict neurological disease development.
Neurovine is developing a concussion research platform that gives patients insights into the health of their brain following a concussion. The platform consists of a wearable headband that utilizes electroencephalogram (EEG) and machine learning to provide patients with real-time reports on brain health. The platform and accompanying heart rate monitor can help patients safely recover from concussions.
X-Bolt develops next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.
EFA developed RevDx™, a revolutionary, CE-approved, mobile, and fully automated diagnostic system for the point of care, including primary care physicians, home-care, emergency, and remote locations. A very easy-to-use process from a finger prick to results in a few minutes. The first application is the Complete Blood Count test and more to follow
CorWave's wave membrane is a proprietary biomimetic technology that efficiently propells fluids. The technology has been applied to two technologies, a left ventricular assist device (LVAD) and an implantable, minimally invasive cardiac pump to provide support to heart failure patients who are not eligible for LVADs.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
Aortyx is developing a solution for the treatment of aortic dissection. The company is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site.
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being.
Designer and manufacturer of medical simulation products. Core range of simulators includes ‘take-home’ laparoscopic simulators and a range of institutional based laparoscopic simulators. The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.
Paragate Medical is developing an implantable peritoneal ultrafiltration device that functions as a mechanical bypass too the kidneys and maintain fluid balance in patients with kidney or chronic heart failure.
Onera Health develops diagnostic and monitoring solutions to help people with sleep-related ailments. The company's Onera STS wearable sleep system collects comprehensive sleep data which allows providers to optimize patient care and reduce costs.
Endoron is developing a long-lasting solution for the treatment of abdominal aortic aneurysm (AAA). The company's Aortoseal system uses a smart stapling system that penetrates the aortic wall and stent graft to secure the graft in place in a variety of anatomies.
Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.
BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
Andrew A. Dahl, Founder & Chairman BioMEMS Diagnostics
Rapid Nexus Nanotech Wound Solutions is an innovative wound company whose technology is based on nanomaterials and targets the electromagnetic cell division cycles (anaphase through telophase) to accelerate growth of tissue.
We repair infected and complex high-risk wounds and have already prevented amputations due to diabetes.
Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Locate Bio specializes in the development of orthobiologics for orthopedic surgery. The company's orthobiologic products leverage Locate Bio's expertise in programmed drug release and instructive tissue scaffolds to enhance the tissue repair process.
SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science.
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
Gradient Denervation Technologies is using thermal ablation to reduce pulmonary pressure in patients with pulmonary hypertension. The technology will target the nerves responsible for the hyperactivity of the pulmonary artery nerves to produce a long-term reduction in pulmonary pressure.
Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy.
HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.
Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
Manny Villafana, Founder of St. Jude Medical, ATS, Cardiac Pacemakers Medical 21
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues.
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.